Linkage Global (Nasdaq: UZX) has regained compliance with Nasdaq’s minimum bid price requirement for continued listing on the Nasdaq Capital Market.
Its Class A ordinary shares maintained a closing bid price of at least US$1.00 for 20 consecutive business days from September 21 through October 16, 2026. Nasdaq confirmed compliance in written notification on October 19 and closed the matter. The company had received a deficiency notice on June 3 after its closing bid price remained below US$1.00 for 30 consecutive business days. Its initial 180-calendar-day compliance period ran through November 30, 2026; regaining compliance required at least 10 consecutive business days at or above the threshold.
Linkage Global (NASDAQ: UZX) terminated its non-binding investment letter of intent with Capital Finance, effective September 28, 2026.
The proposed equity investment was for up to US$20 million. Capital Finance acknowledged and agreed to the written termination notice, and the parties will not proceed. No definitive securities purchase agreement was signed, no securities were issued and no funds were received. The agreement ceased to have further effect except for surviving provisions; confidentiality obligations remain for three years following termination. The company plans to continue evaluating strategic and financing opportunities.
Linkage Global (UZX) will implement a 23-for-1 share consolidation effective at the open of trading on September 21, 2026.
Shareholders approved the consolidation on September 8, 2026, with the stated aim of helping the company regain compliance with Nasdaq Marketplace Rule 5550(a)(2) and maintain its Nasdaq Capital Market listing. Each 23 ordinary shares will automatically combine into 1 share without shareholder action, and no fractional shares will be issued; instead, each shareholder will receive 1 share in lieu of any fractional entitlement.
Authorised Class A shares will be reduced from 998,000,000 to about 43,391,304 and Class B from 12,000,000 to about 521,739, while issued and outstanding Class A shares will fall from 69,732,831 to approximately 3,031,862 and Class B from 7,000,000 to approximately 304,348, all subject to rounding.
Linkage Global (UZX) signed a non-binding term sheet with Capital Finance Limited for a proposed two-tranche PIPE equity investment of up to US$20 million.
The first tranche is a US$5 million direct PIPE in newly issued Class A ordinary shares at US$3.00 per share or 105% of the prior trading day’s closing price, whichever is higher, targeting a first closing as early as September 30, 2026. At a US$3.00 baseline, this implies about 1,666,667 new shares. Within 30 business days after this closing, the parties plan to identify an AI hardware manufacturing acquisition target valued between US$20 million and US$50 million.
Following execution of an acquisition agreement, Capital Finance plans a second PIPE of up to US$15 million, priced at the higher of US$3.00 or 105% of the share’s prior close. The combined shares from both tranches will not exceed 49% of Linkage Global’s outstanding Class A shares, and the structure excludes warrants, convertibles, options or anti-dilution features. The LOI includes a 60-day due diligence period and customary exclusivity but remains largely non-binding.
Linkage Global (NASDAQ: UZX) announced that Professor Zeng Yan, Chief Scientist at ClickClack, an intellectual property partner of Linkage Global, received the “Clinical Contribution Award for Deep Coma Awakening” from the Coma Arousal and Rehabilitation Center for Brain Disorders at Guangdong Second Hospital of Traditional Chinese Medicine.
The award recognizes a two-year, uncontrolled, single-center observational study in 407 deep coma patients using a non-invasive protocol combining “micro-brain” sound wave music with traditional acupuncture. According to Linkage Global, 32 patients (7.86%) awakened and 252 (61.9%) showed ≥9-point increases on the Glasgow Coma Scale, but the company cautions these outcomes cannot be attributed to the protocol, are not evidence of safety or efficacy, and have not been peer reviewed or assessed by regulators.
Building on these data, Linkage Global and the Hospital are starting a second-stage (“Phase II”) investigational research program on non-pharmacological approaches to cognitive impairment and sleep disorders, which is not a regulated clinical trial phase and carries no assurance of completion, positive results, or commercial products.
Linkage Global (NASDAQ: UZX) announced on August 11, 2026 that it is evaluating opportunities to apply its AI-enabled acoustic wellness technology in the hotel and hospitality sector. The proposed Emotional Frequency Tuning hotel empowerment solution would integrate acoustic algorithms and smart hardware into guest rooms, spas, and wellness spaces.
According to the company, potential deployments could use Frequency Following Response technology, proprietary acoustic instruments, and nature sound libraries, combined with ClickClack smart headphones, resonance massage pads, and ambient soundscape systems. Linkage Global is assessing possible commercial partnerships, but no hotel agreements have been entered into so far.
Linkage Global (NASDAQ: UZX) announced a strategic transformation into an AI-driven psychoacoustics and wellness infrastructure platform centered on its new Human Resonance OS, moving beyond traditional hardware and e-commerce models. Hardware, led by licensed smart headphones, will primarily function as a data and user acquisition layer for a higher-margin digital ecosystem.
The Human Resonance OS is designed to combine proprietary AI neural audio algorithms, real-time emotional computing, and cloud-based wellness services. It connects elements such as original wellness audio copyrights, AI digital companionship, an upcoming AI wellness app, and deployments in smart homes, corporate wellness, AI pods, and immersive “sonic cinema” environments.
Linkage Global (NASDAQ: UZX) reported unaudited results for the six months ended March 31, 2026. Total revenues fell 25.22% to $2.62 million, while gross profit declined 10.43% to $2.42 million. Net loss narrowed 45.91% to $1.67 million.
Integrated e-commerce services revenue dropped 30.01% to $1.89 million and cross-border sales decreased 98.97% to $8,278. A new headset trademark and patent licensing business contributed $720,000 at 100% gross margin. Operating expenses decreased 5.04% to $4.12 million, with general and administrative expenses down 44.90%.
Linkage Global (NASDAQ: UZX) announced a strategic upgrade to build a global AI-enabled wellness ecosystem, combining generative AI, proprietary music copyrights and smart wearable hardware.
The company expects about $8 million in annual partnership revenue and reports ClickClack licensed smart headphone sales trending toward $1 million in monthly revenue.
Linkage Global (Nasdaq: UZX) received a Nasdaq notice on June 3, 2026 that its Class A shares no longer meet the $1 minimum bid price requirement under Rule 5550(a)(2) after 30 consecutive business days below that level.
The notice does not immediately affect listing or trading, and UZX will continue on Nasdaq. Linkage Global has a 180-day compliance period until November 30, 2026, with a possible additional 180 days if certain criteria are met. The company is evaluating options, including a potential reverse stock split, but warns there is no assurance it will regain compliance or satisfy all continued listing requirements.